NASDAQ:XOMA
XOMA Corporation Stock News
$24.78
-0.660 (-2.59%)
At Close: May 03, 2024
XOMA Co. (NASDAQ:XOMA) Stock Position Raised by State Street Corp
11:50am, Tuesday, 30'th Nov 2021 Transcript Daily
State Street Corp lifted its stake in XOMA Co. (NASDAQ:XOMA) by 13.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 120,424 shares of the biotechnology companys stock after acquiring an additional 14,475 shares during the period. State Street Corp owned 1.06% of XOMA worth $4,094,000 []
Botulinum Market Expansion Projected to Gain an Uptick During 2021-2027 Covid-19 Analysis | XOMA, AlphaVax
04:53pm, Monday, 22'nd Nov 2021 OpenPR
Another exploration Titled "Worldwide Botulinum 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central point, for
BioAge appoints Dov Goldstein as Chief Financial Officer and Ann Neale as Chief Development Officer
01:00pm, Wednesday, 17'th Nov 2021 Kwhen FinanceStrength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength?
04:53am, Friday, 08'th Oct 2021
Xoma (XOMA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
07:30am, Wednesday, 22'nd Sep 2021
EMERYVILLE, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA)'s Chief Executive Officer, Jim Neal, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Confere
XOMA Declares Quarterly Preferred Stock Dividends
07:30am, Monday, 20'th Sep 2021
EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash divide
XOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07:30am, Monday, 13'th Sep 2021
EMERYVILLE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present at the H.C. Wainwright 23rd Annual Global Inv
I Put Half Of My Retirement Savings Into These Investments
08:35am, Thursday, 02'nd Sep 2021
Half of my retirement savings is invested in two sectors.
XOMA Announces Heather L. Franklin Joins its Board of Directors
04:35pm, Tuesday, 10'th Aug 2021
EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Heather L. Franklin, President and Chief Executive Officer of Blaze Bioscience, Inc., has joined t
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events
07:30am, Thursday, 05'th Aug 2021
Added six assets to its portfolio of potential milestone and royalty assets in 2021
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Ad hoc announcement pursuant to Article 53 of the SIX listing rules
XOMA Acquires Royalty and Milestone Interest in Checkmate's Vidutolimod (CMP-001) from Kuros Biosciences
04:00am, Thursday, 15'th Jul 2021
EMERYVILLE, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the royalty interest position Kuros Biosciences holds in Checkmate Pharmaceutical
Stem, Tesla, Textron, Two Harbors and More Tuesday Afternoon Analyst Calls
01:16pm, Tuesday, 29'th Jun 2021
Stocks were mostly higher in midday Tuesday trading, after both the S&P 500 and the Nasdaq closed at record highs on Monday.
XOMA Declares Quarterly Preferred Stock Dividends
07:30am, Monday, 21'st Jun 2021
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividen
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
08:00am, Friday, 21'st May 2021
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) recently learned its licensees are presenting at the upcoming 2021 American Society of Clinical Oncology (ASCO) An